Breast Cancer Trial, Not Yet Recruiting NCT07132502 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07132502
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with HER-2 positive breast cancer (confirmed through laboratory testing of tissue samples using specific methods called immunohistochemistry or FISH), at an advanced stage.
  • People whose cancer has shown a complete response — meaning scans using PET-CT or contrast-enhanced CT have shown no signs of active cancer — after receiving a second round of cancer treatment, and this response has been maintained for at least 3 months.
  • People whose blood test shows no detectable circulating tumour DNA (tiny fragments of cancer DNA in the blood), which is a marker used to check for remaining traces of cancer.
  • People whose blood test shows a negative result for CA153, a protein marker sometimes associated with breast cancer.
  • People with a general health and activity level rated at 0, 1, or 2 on a standard medical scale (where 0 means fully active and 2 means up and about more than half the day but unable to do physical work) (confirm with trial site).
  • People whose expected survival is at least 6 months, as assessed by their medical team.
  • People who have signed a consent form agreeing to take part in the study and to attend regular follow-up appointments.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who currently have or have been diagnosed with another type of cancer (other than breast cancer).
  • People with a history of mental health conditions or difficulties with thinking and memory that would prevent them from participating in the study.
  • People who are currently pregnant or breastfeeding.
  • People with serious heart, liver, or kidney problems.
  • People who are currently taking part in another clinical trial that could affect the results of this study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 1 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
25 August 2025
Est. completion
8 July 2027

Primary endpoints

Progression - free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov